Skip to main content
Clinical Trials/NCT00455455
NCT00455455
Completed
Phase 4

Corneal and Conjunctival Sensitivity and Staining Study

University of Waterloo1 site in 1 country50 target enrollmentMarch 2007

Overview

Phase
Phase 4
Intervention
Optifree RepleniSH Multipurpose Disinfecting Solution
Conditions
Myopia
Sponsor
University of Waterloo
Enrollment
50
Locations
1
Primary Endpoint
Corneal Sensitivity
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The primary objective of this study is to compare subjective symptoms and ocular health in a group of individuals who are currently wearing soft contact lenses on a daily wear basis, after a short period of no lens wear and during the time course when using differing care regimens.

Detailed Description

The primary objective of this study is to compare subjective symptoms and ocular health in a group of individuals who are currently wearing soft contact lenses on a daily wear basis, after a short period of no lens wear and during the time course when using differing care regimens. Observations will be made to monitor physiology.

Registry
clinicaltrials.gov
Start Date
March 2007
End Date
December 2008
Last Updated
15 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • An eligible participant is one who:
  • Is between 17-45 years old and has full legal capacity to volunteer.
  • Has read and signed an information consent letter, after having the opportunity to ask questions and receive acceptable answers.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Does not experience any dryness related symptoms during lens wear (i.e. at least 12 hours of comfortable wearing time)
  • Is correctable to a visual acuity of 6/7.5 (20/25) or better (each eye) with their habitual vision correction.
  • Has normal binocular vision (no strabismus, no amblyopia).
  • Has clear corneas and no active ocular disease.
  • Has had an ocular examination in the last two years. Has a distance contact lens prescription between +0.50D to +6.00 DS and -0.50D and -12.00 DS.
  • Has astigmatism less than or equal to -1.00DC.

Exclusion Criteria

  • A person is ineligible if he/she:
  • Has undergone corneal refractive surgery.
  • Is aphakic.
  • Has any active ocular disease.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that may affect ocular health.
  • Has a known sensitivity to the diagnostic pharmaceuticals to be used in the study.
  • Is pregnant or lactating.
  • Is participating in any other clinical or research study.
  • Has a known clinically significant sensitivity to the contact lens care solutions used in the study.

Arms & Interventions

Optifree RepleniSH Multipurpose Disinfecting Solution

Intervention: Optifree RepleniSH Multipurpose Disinfecting Solution

ReNu Multiplus Multipurpose Solution

Intervention: ReNu Multiplus Multipurpose Solution

Outcomes

Primary Outcomes

Corneal Sensitivity

Time Frame: day 7

The detection threshold, the lowest level at which a stimulus to the cornea in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.

Conjunctival Sensitivity

Time Frame: day 7

The detection threshold, the lowest level at which a stimulus to the conjunctiva in a unit of percent CO2 can be detected was measured. Sensitivity is the reciprocal of the detection threshold.

Secondary Outcomes

  • Corneal Staining Grade(day 7)

Study Sites (1)

Loading locations...

Similar Trials